A Retrospective Study of IV Transmitted Diseases through Blood Products among Blood Donors at AIMTH
DOI:
https://doi.org/10.60127/sjms.3.4.2025.81Keywords:
HBV, HCV, HIV, TTIs, infections, syphilis, malaria, transfusion transmitted diseasesAbstract
Objectives: To assess the Frequency of IV transmitted Diseases through blood products among blood donors at AIMTH, Sialkot.
Methodology: An observational retrospective study was conducted in August 2023.The data was collected from June 2022 to July 2023 from the Blood Bank of Allama Iqbal Memorial Teaching hospital Sialkot. The data was collected and analysed for the frequency of diseases (hepatitis B, hepatitis C, VDRL/syphilis, HIV and malaria) transmitted through transfusion among 3287 Blood Donors” Allama Iqbal Memorial Teaching hospital Sialkot.
Results: Amongst 3287 blood donations, 1.61 % (n = 53) were infected at least with one pathogen, HCV positive cases were 0.73% (n = 24), syphilis positive were 0.49% (n = 14) HBV positive cases were 0.36% (n = 12), HIV positive cases were only 0.03% (n=1) and malaria 00 (0%) in decreasing order. Out of 3287, 95% (n= 3123) were males and 5% (n=164) were females.
Conclusion: Our research concludes that there is little chance of transmission by transfusion. Just 53 out of the 3287 blood donors in this study had a TTI diagnosis.
Keywords: HBV; HCV; HIV; TTIs; infections; syphilis; malaria; transfusion transmitted diseases.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Awais Saleh, Muhammad Mukarrum Saleh, Mehak Fatima, Javeria Aslam Butt, Amna Asghar, Imtiaz Ahmad (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright to their work and grant the Sial Journal of Medical Sciences the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
